A prospective randomized comparison of sublingual and oral misoprostol when combined with mifepristone for medical abortion at 12-20 weeks gestation.

被引：0
|
作者：
Tang, O [1 ]
Chan, C [1 ]
Kan, A [1 ]
Ho, P [1 ]
机构：
[1] Univ Hong Kong, Hong Kong, Peoples R China
来源：
FERTILITY AND STERILITY | 2005年 / 84卷
关键词：
D O I：
10.1016/j.fertnstert.2005.07.414
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页码：S168 / S168
页数：1
相关论文
共 46 条
  • [31] Comparison of the efficacy of sublingual, oral, and vaginal administration of misoprostol in the medical treatment of missed abortion during first trimester of pregnancy: A randomized clinical trial study
    Souizi, Behnaz
    Akrami, Rahim
    Borzoee, Fateme
    Sahebkar, Mohammad
    JOURNAL OF RESEARCH IN MEDICAL SCIENCES, 2020, 25
  • [32] BUCCAL MISOPROSTOL COMPARED WITH DILAPAN-S BEFORE SURGICAL ABORTION BETWEEN 12 AND 15 WEEKS' GESTATION: A RANDOMIZED CONTROLLED TRIAL
    Bartz, D.
    CONTRACEPTION, 2012, 86 (03) : 291 - 291
  • [33] THE EXTENDED GESTATIONAL AGE MEDICAL ABORTION STUDY: THE EFFECTIVENESS OF MEDICAL ABORTION WITH 200 MG MIFEPRISTONE AND 400 MCG SUBLINGUAL MISOPROSTOL AT 57-63 DAYS VS. 64-70 DAYS GESTATION
    Bracken, H.
    Attia, M. B.
    Chelli, H.
    Dabash, R.
    Hajri, S.
    Mundle, S.
    Platais, I
    Posohova, S.
    Raghavan, S.
    Shah, M.
    Swica, Y.
    Tsereteli, T.
    Tsertsvadze, G.
    Winikoff, B.
    Zerarmdini, D.
    CONTRACEPTION, 2011, 84 (03) : 303 - 303
  • [34] A randomized comparison of oral mifepristone to intravenous oxytocin for labor induction in women with prelabor rupture of membranes beyond 36 weeks' gestation
    Wing, DA
    Guberman, C
    Fassett, M
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2005, 192 (02) : 445 - 451
  • [35] A randomized double-blind placebo-controlled study to assess the effect of oral contraceptive pills on the outcome of medical abortion with mifepristone and misoprostol
    Tang, OS
    Gao, PP
    Cheng, LN
    Lee, SWH
    Ho, PC
    HUMAN REPRODUCTION, 1999, 14 (03) : 722 - 725
  • [36] A two-pill sublingual misoprostol outpatient regimen following mifepristone for medical abortion through 70 days' LMP: a prospective comparative open-label trial
    Bracken, Hillary
    Dabash, Rasha
    Tsertsvadze, George
    Posohova, Svetlana
    Shah, Milind
    Hajri, Selma
    Mundle, Shuchita
    Chelli, Hela
    Zeramdini, Dhouha
    Tsereteli, Tamar
    Platais, Ingrida
    Winikoff, Beverly
    CONTRACEPTION, 2014, 89 (03) : 181 - 186
  • [37] Two prophylactic medication approaches in addition to a pain control regimen for early medical abortion < 63 days’ gestation with mifepristone and misoprostol: study protocol for a randomized, controlled trial
    Monica V. Dragoman
    Daniel Grossman
    Nathalie Kapp
    Nguyen My Huong
    Ndema Habib
    Duong Lan Dung
    Anand Tamang
    Reproductive Health, 13
  • [38] Randomized comparison of vaginal (200 μg every 3 h) and oral (400 μg every 3 h) misoprostol when combined with mifepristone in termination of second trimester pregnancy
    Ngai, SW
    Tang, OS
    Ho, PC
    HUMAN REPRODUCTION, 2000, 15 (10) : 2205 - 2208
  • [39] Two prophylactic medication approaches in addition to a pain control regimen for early medical abortion &lt; 63 days' gestation with mifepristone and misoprostol: study protocol for a randomized, controlled trial
    Dragoman, Monica V.
    Grossman, Daniel
    Kapp, Nathalie
    Nguyen My Huong
    Habib, Ndema
    Duong Lan Dung
    Tamang, Anand
    REPRODUCTIVE HEALTH, 2016, 13 : 1 - 10
  • [40] Telemedicine medical abortion at home under 12 weeks' gestation: a prospective observational cohort study during the COVID-19 pandemic
    Reynolds-Wright, John Joseph
    Johnstone, Anne
    McCabe, Karen
    Evans, Emily
    Cameron, Sharon
    BMJ SEXUAL & REPRODUCTIVE HEALTH, 2021, 47 (04) : 246 - 251
12345